CRISIL Ltd. Downgraded to Sell Amid Valuation Concerns and Mixed Financial Trends

Quality Assessment: Strong Fundamentals Amidst Growth Concerns

CRISIL continues to demonstrate high-quality operational metrics, reflected in its latest return on equity (ROE) of 27.03% and return on capital employed (ROCE) of 40.16%. These figures underscore the company’s efficient capital utilisation and profitability. The firm remains net-debt free, further bolstering its financial stability and reducing risk exposure. Additionally, the management’s effectiveness is evident in the consistent growth of profits, with the latest quarter (Q1 FY26-27) reporting a 26.2% increase in PAT to ₹216.46 crores and a 27.56% rise in net sales to ₹1,075.39 crores.

However, despite these positives, the company’s long-term growth trajectory raises concerns. Net sales have expanded at a compounded annual growth rate (CAGR) of 14.40% over the past five years, which is modest relative to sector expectations. This slower growth rate, combined with the stock’s premium valuation, has contributed to the cautious stance on quality from an investment perspective.

Valuation: From Expensive to Very Expensive

The most significant factor behind the downgrade is the sharp increase in valuation multiples, pushing CRISIL into the “very expensive” category. The price-to-earnings (PE) ratio stands at 37.59, considerably higher than peers such as CARE Ratings (PE 30.32) and ICRA (PE 25.24). The price-to-book value ratio is also elevated at 10.16, signalling a premium price relative to the company’s net asset value.

Enterprise value multiples further highlight the stretched valuation: EV to EBIT at 30.23, EV to EBITDA at 26.57, and EV to capital employed at 12.14. The PEG ratio of 1.75, while not extreme, suggests that earnings growth is not sufficiently compensating for the high price levels. Dividend yield remains modest at 1.39%, offering limited income support to investors.

This valuation premium is not fully justified by the company’s growth prospects or recent performance, leading to a downgrade in the valuation grade from “expensive” to “very expensive.”

Financial Trend: Mixed Signals from Recent Performance

CRISIL’s recent quarterly results have been encouraging, with net sales growing 27.56% year-on-year and profit before tax (excluding other income) rising 28.43% to ₹258.70 crores. These figures indicate operational strength and effective cost management. Over the past year, profits have increased by 21.5%, reflecting solid earnings momentum despite a challenging market environment.

However, the stock’s price performance tells a different story. Over the last 12 months, CRISIL’s share price has declined by 12.75%, significantly underperforming the broader BSE500 index, which has gained 4.47% in the same period. This divergence suggests that market sentiment is cautious, possibly due to concerns over valuation and growth sustainability.

Longer-term returns present a more balanced picture. Over five years, CRISIL has delivered a 59.54% return, outperforming the Sensex’s 45.46% gain. Yet, over the past year, the negative price trend has weighed on investor confidence, contributing to the downgrade in the financial trend rating.

Technicals: Short-Term Momentum and Market Sentiment

From a technical perspective, CRISIL’s stock price has shown some resilience in recent weeks, with a 1.71% gain on 7 August 2026 and a one-month return of 14.55%, outperforming the Sensex’s 0.86% over the same period. The stock traded within a range of ₹4,427.80 to ₹4,570.00 on the day, closing near ₹4,547.65, close to its 52-week high of ₹5,449.95.

Despite this short-term strength, the overall technical outlook remains cautious due to the stock’s underperformance over the past year and the stretched valuation multiples. The market appears to be pricing in limited upside potential, reflecting a “Sell” grade in the technical assessment.

Summary of Ratings and Grades

As of 6 August 2026, CRISIL’s overall Mojo Score stands at 48.0, with a Mojo Grade of Sell, downgraded from Hold. The valuation grade has been downgraded from expensive to very expensive, while quality remains strong but tempered by moderate growth. Financial trends show mixed signals, with strong quarterly earnings but weak price performance over the past year. Technical indicators suggest cautious optimism but limited conviction.

The company is classified as a small-cap within the capital markets sector, with promoters holding the majority stake, ensuring stable ownership and governance.

Investment Implications

Investors considering CRISIL must weigh the company’s strong financial health and management efficiency against its stretched valuation and subdued long-term growth outlook. The downgrade to Sell reflects a cautious stance, signalling that the current price does not adequately compensate for the risks associated with limited growth and high multiples.

While the company’s net-debt-free status and robust profitability metrics are positives, the market’s underwhelming price performance over the past year and the very expensive valuation grade suggest limited upside in the near term. Investors may prefer to explore better-valued peers or alternative sectors offering more attractive risk-reward profiles.

Given these factors, CRISIL’s current rating advises prudence, with a focus on valuation discipline and monitoring of future earnings growth before considering fresh exposure.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today